New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:22 EDTBCR, MDTC.R. Bard Lutonix balloon has 50% chance for approval at best, says Wells Fargo
After reviewing briefing materials posted to the FDA's website for an upcoming advisory committee meeting, Wells Fargo said it expects a "very tough" panel for C.R. Bard's (BCR) Lutonix drug-coated balloon and puts the chance of approval for the product at 50% "at best." Additionally, the firm does not think Bard's data is competitive with stents, which are the standard of care, or with data on Medtronic's (MDT) competing balloon.
News For BCR;MDT From The Last 14 Days
Check below for free stories on BCR;MDT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
09:45 EDTBCRC.R. Bard downgraded to Underperform from Neutral at BofA/Merrill (pre-open)
July 28, 2014
12:46 EDTMDTMedtronic receives FDA approval for PRESTIGE cervical disc system
Subscribe for More Information
11:07 EDTMDTLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy, along with MEDACorp Specialist Arie Pieter Kappetein, MD, PhD and Bernhard Meier, MD, assess EU cardiology trends on an Analyst/Industry conference call to be held on July 31 at 3 pm.
06:52 EDTMDTFormer official says Obama could limit inversion deals, NY Times reports
President Obama could limit tax inversion deals on his own authority, said Stephen Shay, former deputy assistant Treasury secretary for international tax affairs in the Obama administration, according to The New York Times. A 1969 law gives the president the ability to restrict inversion deals, said Shay, who also worked in the Reagan administration, the newspaper stated. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Alletgan (AGN). Reference Link
July 25, 2014
06:30 EDTMDTObama calls on Congress to end inversion deals, NY Times reports
Subscribe for More Information
July 24, 2014
17:36 EDTBCRC.R. Bard raises FY14 EPS view to $8.25-$8.35 from $8.20-$8.30
Subscribe for More Information
17:34 EDTBCRC.R. Bard sees Q3 EPS $2.07-$2.11, consensus $2.09
Subscribe for More Information
16:25 EDTBCRC.R. Bard reports Q2 adjusted EPS $2.06, consensus $2.01
Subscribe for More Information
08:19 EDTMDTLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
July 21, 2014
08:16 EDTMDTDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
July 18, 2014
12:51 EDTMDTKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
July 16, 2014
10:36 EDTMDTTreasury calls on Congress to halt inversion deals
Subscribe for More Information
07:59 EDTMDTTreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
07:18 EDTMDTScoliosis Research Society to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use